Zkusit zdarma
Kiniksa Pharmaceuticals, Ltd.

Kiniksa Pharmaceuticals, Ltd.

KNSA
Cena:
$ 53.24
-0.41 (-0.76%)
Valuace
0
Růst
70
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Kiniksa: Increased Outlook For Arcalyst, Augmented By Pipeline Maturation

Kiniksa: Increased Outlook For Arcalyst, Augmented By Pipeline Maturation

11:10 29-04-2026

Kiniksa Pharmaceuticals continues to outperform, with Arcalyst net sales poised to surpass my previo...

Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today

Why Kiniksa Pharmaceuticals International Stock Raced Nearly 24% Higher Today

19:10 28-04-2026

Its Arcalyst has been on the market for years, yet it posted strong sales growth in the period. More...

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript

17:21 28-04-2026

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript...

Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) Tops Q1 Earnings and Revenue Estimates

9:46 28-04-2026

Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per shar...

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution

7:30 28-04-2026

- ARCALYST (rilonacept) Q1 2026 net product revenue of $214. 3 million, representing 56% year-over-y...

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026

16:01 23-04-2026

LONDON, April 23, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA)...

What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge

What This $309K Kiniksa Insider Sale Might Signal Amid a 120% Stock Surge

16:56 17-04-2026

The chief accounting officer of Kiniksa Pharmaceuticals sold 6,625 shares for roughly $309,000 on Ap...

Ross Moat Sells 1,703 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock

Ross Moat Sells 1,703 Shares of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Stock

4:58 15-04-2026

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA - Get Free Report) COO Ross Moat sold 1,703...

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis

8:00 08-04-2026

– Educational campaign to raise awareness of recurrent pericarditis and to empower patients to dis...

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High – Still a Buy?

Kiniksa Pharmaceuticals International (NASDAQ:KNSA) Reaches New 12-Month High – Still a Buy?

4:57 07-04-2026

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA - Get Free Report) hit a new 52-week high d...

Aberdeen Group plc Buys 241,876 Shares of Kiniksa Pharmaceuticals International, plc $KNSA

Aberdeen Group plc Buys 241,876 Shares of Kiniksa Pharmaceuticals International, plc $KNSA

3:09 07-04-2026

Aberdeen Group plc grew its stake in shares of Kiniksa Pharmaceuticals International, plc (NASDAQ: K...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of “Moderate Buy” from Analysts

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Receives Consensus Rating of “Moderate Buy” from Analysts

2:54 09-03-2026

Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA - Get Free Report) has been assigned a cons...

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript

11:18 24-02-2026

Kiniksa Pharmaceuticals International, plc (KNSA) Q4 2025 Earnings Call Transcript...

Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates

Kiniksa Pharmaceuticals International, plc (KNSA) Misses Q4 Earnings Estimates

10:40 24-02-2026

Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.17 per shar...

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution

Kiniksa Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Portfolio Execution

7:30 24-02-2026

– ARCALYST ® (rilonacept) Q4 2025 and full year 2025 net product revenue of $202.1 million and $6...

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

Kiniksa Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

16:01 19-02-2026

LONDON, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) ...

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

Kiniksa Pharmaceuticals International, plc (KNSA) Earnings Expected to Grow: Should You Buy?

11:01 17-02-2026

Kiniksa Pharmaceuticals International, plc (KNSA) doesn't possess the right combination of the two k...

Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator

Kiniksa: Arcalyst Is The Engine, But KPL-387 Is The Accelerator

0:40 24-01-2026

Kiniksa transitions from survival risk to growth, targeting dominance in the pericarditis market wit...

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Consensus Recommendation of “Moderate Buy” by Brokerages

3:30 18-01-2026

Shares of Kiniksa Pharmaceuticals International, plc (NASDAQ: KNSA - Get Free Report) have earned an...

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

19:35 12-01-2026

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at 44th Annual J.P. Morgan Healthcare Con...

close

KINIKSA PHARMACEUTICALS PROVIDES CORPORATE UPDATE

12-01-2026
– ARCALYST ® (RILONACEPT) 2025 NET PRODUCT REVENUE OF $677.5 MILLION (UNAUDITED), REPRESENTING ~6...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

07-01-2026
LONDON, JAN. 07, 2026 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT JEFFERIES GLOBAL HEALTHCARE CONFERENCE IN LONDON

12-11-2025
LONDON, NOV. 12, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

28-10-2025
– ARCALYST ® (RILONACEPT) Q3 2025 NET PRODUCT REVENUE OF $180.9 MILLION, REPRESENTING 61% YEAR-OV...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT THIRD QUARTER 2025 FINANCIAL RESULTS ON OCTOBER 28, 2025

23-10-2025
LONDON, OCT. 23, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS ANNOUNCES U.S. ORPHAN DRUG DESIGNATION FOR KPL-387 FOR THE TREATMENT OF PERICARDITIS

17-10-2025
LONDON, OCT. 17, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

28-08-2025
LONDON, AUG. 28, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS REPORTS SECOND QUARTER 2025 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

29-07-2025
– ARCALYST ® (RILONACEPT) Q2 2025 NET PRODUCT REVENUE OF $156.8 MILLION, REPRESENTING 52% YEAR-OV...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT SECOND QUARTER 2025 FINANCIAL RESULTS ON JULY 29, 2025

24-07-2025
LONDON, JULY 24, 2025 (GLOBE NEWSWIRE) --  KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA...
Více zde

KINIKSA PHARMACEUTICALS ANNOUNCES TRIAL DESIGN OF PLANNED PHASE 2/3 CLINICAL TRIAL OF KPL-387 IN RECURRENT PERICARDITIS

05-06-2025
– KPL-387 PHASE 2/3 TRIAL ON TRACK TO INITIATE IN MID-2025; PHASE 2 DATA EXPECTED IN 2H 2026 – ...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT UPCOMING INVESTOR CONFERENCES

29-05-2025
LONDON, MAY 29, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS ANNOUNCES GRAMMY® AWARD-WINNING COUNTRY STAR, CARLY PEARCE, JOINS THE LIFE DISRPTED™ CAMPAIGN, ADDING TO VOICES ADVOCATING FOR AWARENESS OF RECURRENT PERICARDITIS

30-04-2025
– PEARCE JOINS NHL HALL-OF-FAMER, HENRIK LUNDQVIST, TO EDUCATE PATIENTS AND CAREGIVERS ABOUT THE I...
Více zde

KINIKSA PHARMACEUTICALS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

29-04-2025
– ARCALYST ® (RILONACEPT) Q1 2025 NET PRODUCT REVENUE OF $137.8 MILLION, REPRESENTING 75% YEAR-OV...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT FIRST QUARTER 2025 FINANCIAL RESULTS ON APRIL 29, 2025

24-04-2025
LONDON, APRIL 24, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

25-02-2025
– ARCALYST ® (RILONACEPT) Q4 2024 AND FULL YEAR 2024 NET PRODUCT REVENUE OF $122.5 MILLION AND $4...
Více zde

KINIKSA PHARMACEUTICALS ANNOUNCES DEVELOPMENT OF KPL-387 IN RECURRENT PERICARDITIS AND UPDATES CORPORATE STRATEGY

25-02-2025
– KINIKSA PLANS TO INITIATE A PHASE 2/3 CLINICAL TRIAL OF KPL-387 IN RECURRENT PERICARDITIS IN MID...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS ON FEBRUARY 25, 2025

20-02-2025
LONDON, FEB. 20, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS REPORTS PRELIMINARY 2024 NET PRODUCT REVENUE AND PROVIDES 2025 NET PRODUCT REVENUE GUIDANCE

13-01-2025
– ARCALYST ® (RILONACEPT) 2024 NET PRODUCT REVENUE OF $416.4 MILLION (UNAUDITED), REPRESENTING ~7...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2025
LONDON, JAN. 06, 2025 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT 7TH ANNUAL EVERCORE ISI HEALTHCONX CONFERENCE

26-11-2024
LONDON, NOV. 26, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT JEFFERIES LONDON HEALTHCARE CONFERENCE

12-11-2024
LONDON, NOV. 12, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

29-10-2024
– ARCALYST ® (RILONACEPT) Q3 2024 NET PRODUCT REVENUE OF $112.2 MILLION, REPRESENTING 73% YEAR-OV...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT THIRD QUARTER 2024 FINANCIAL RESULTS ON OCTOBER 29, 2024

22-10-2024
LONDON, OCT. 22, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT 2024 WELLS FARGO HEALTHCARE CONFERENCE

28-08-2024
LONDON, AUG. 28, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA)...
Více zde

KINIKSA PHARMACEUTICALS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS AND RECENT PORTFOLIO EXECUTION

23-07-2024
– ARCALYST ® (RILONACEPT) Q2 2024 NET PRODUCT REVENUE OF $103.4 MILLION, REPRESENTING 90% YEAR-OV...
Více zde

KINIKSA PHARMACEUTICALS TO REPORT SECOND QUARTER 2024 FINANCIAL RESULTS ON JULY 23, 2024

16-07-2024
LONDON, JULY 16, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC (NASDAQ: KNSA) ...
Více zde

KINIKSA PHARMACEUTICALS COMMENCES ENROLLMENT IN ABIPRUBART PHASE 2B CLINICAL TRIAL IN SJÖGREN'S DISEASE

09-07-2024
– ABIPRUBART PHASE 2B CLINICAL TRIAL IN SJÖGREN'S DISEASE TO EVALUATE TREATMENT RESPONSE ACROSS B...
Více zde

KINIKSA PHARMACEUTICALS SPONSORS AMERICAN HEART ASSOCIATION'S ADDRESSING RECURRENT PERICARDITIS INITIATIVE

17-06-2024
– INITIATIVE AIMED AT IMPROVING ACCESS AND OUTCOMES FOR PATIENTS WITH RECURRENT PERICARDITIS – ...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT GOLDMAN SACHS 45TH ANNUAL GLOBAL HEALTHCARE CONFERENCE

04-06-2024
HAMILTON, BERMUDA, JUNE 04, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS, LTD. (NASDAQ: KNSA) TO...
Více zde

KINIKSA PHARMACEUTICALS TO PRESENT AT BANK OF AMERICA SECURITIES 2024 HEALTH CARE CONFERENCE

07-05-2024
HAMILTON, BERMUDA, MAY 07, 2024 (GLOBE NEWSWIRE) -- KINIKSA PHARMACEUTICALS, LTD. (NASDAQ: KNSA) TOD...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2026-01-14 00:00:008-KStáhnout
2026-01-12 00:00:008-KStáhnout
2025-10-28 00:00:008-KStáhnout
2025-10-28 00:00:0010-QStáhnout
2025-09-03 01:00:008-KStáhnout
2025-09-03 00:00:008-KStáhnout
2025-07-29 01:00:008-KStáhnout
2025-07-29 01:00:0010-QStáhnout
2025-07-29 00:00:008-KStáhnout
2025-07-29 00:00:0010-QStáhnout
2025-06-05 01:00:008-KStáhnout
2025-06-05 00:00:008-KStáhnout
2025-06-03 01:00:008-KStáhnout
2025-06-03 00:00:008-KStáhnout
2025-04-29 01:00:008-KStáhnout
2025-04-29 01:00:0010-QStáhnout
2025-04-29 00:00:008-KStáhnout
2025-04-29 00:00:0010-QStáhnout
2025-04-23 01:00:008-KStáhnout
2025-04-23 00:00:008-KStáhnout
2025-02-25 00:00:008-KStáhnout
2025-02-25 00:00:0010-KStáhnout
2025-02-24 23:00:008-KStáhnout
2025-02-24 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-10-29 00:00:008-KStáhnout
2024-10-29 00:00:0010-QStáhnout
2024-10-28 23:00:008-KStáhnout
2024-10-28 23:00:0010-QStáhnout
2024-10-07 01:00:008-KStáhnout
2024-10-07 00:00:008-KStáhnout
2024-07-25 01:00:0010-QStáhnout
2024-07-25 00:00:0010-QStáhnout
2024-07-23 01:00:008-KStáhnout
2024-07-23 00:00:008-KStáhnout
2024-06-25 01:00:008-KStáhnout
2024-06-25 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-06-05 01:00:008-KStáhnout
2024-06-05 00:00:008-KStáhnout
2024-04-25 01:00:0010-QStáhnout
2024-04-25 00:00:0010-QStáhnout
2024-04-23 01:00:008-KStáhnout
2024-04-23 00:00:008-KStáhnout
2024-04-02 01:00:008-KStáhnout
2024-04-02 00:00:008-KStáhnout
2024-03-29 00:00:008-KStáhnout
2024-03-28 23:00:008-KStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2024-01-04 00:00:008-KStáhnout
2024-01-03 23:00:008-KStáhnout
2023-11-02 00:00:0010-QStáhnout
2023-11-01 23:00:0010-QStáhnout
2023-10-31 00:00:008-KStáhnout
2023-10-30 23:00:008-KStáhnout
2023-08-01 01:00:0010-QStáhnout
2023-08-01 00:00:0010-QStáhnout
2023-07-25 01:00:008-KStáhnout
2023-07-25 00:00:008-KStáhnout
2023-06-07 01:00:008-KStáhnout
2023-06-07 00:00:008-KStáhnout
2023-05-04 01:00:0010-QStáhnout
2023-05-04 00:00:0010-QStáhnout
2023-05-02 01:00:008-KStáhnout
2023-05-02 00:00:008-KStáhnout
2023-03-13 00:00:008-KStáhnout
2023-03-12 23:00:008-KStáhnout
2023-03-02 00:00:0010-KStáhnout
2023-03-01 23:00:0010-KStáhnout
2023-02-28 00:00:008-KStáhnout
2023-02-27 23:00:008-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-11-03 00:00:0010-QStáhnout
2022-11-02 23:00:0010-QStáhnout
2022-11-01 00:00:008-KStáhnout
2022-10-31 23:00:008-KStáhnout
2022-08-04 01:00:0010-QStáhnout
2022-08-04 00:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 00:00:008-KStáhnout
2022-06-30 01:00:008-KStáhnout
2022-06-30 00:00:008-KStáhnout
2022-05-05 01:00:0010-QStáhnout
2022-05-05 00:00:0010-QStáhnout
2022-05-03 01:00:008-KStáhnout
2022-05-03 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-02-22 00:00:008-KStáhnout
2022-02-21 23:00:008-KStáhnout
2022-01-10 00:00:008-KStáhnout
2022-01-09 23:00:008-KStáhnout
2022-01-03 00:00:008-KStáhnout
2022-01-02 23:00:008-KStáhnout
2021-11-04 00:00:0010-QStáhnout
2021-11-03 23:00:0010-QStáhnout
2021-11-01 00:00:008-KStáhnout
2021-10-31 23:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-08-03 01:00:008-KStáhnout
2021-08-03 00:00:008-KStáhnout
2021-07-06 01:00:008-KStáhnout
2021-07-06 00:00:008-KStáhnout
2021-05-12 01:00:008-KStáhnout
2021-05-12 00:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-05-04 01:00:008-KStáhnout
2021-05-04 00:00:008-KStáhnout
2021-04-28 01:00:008-KStáhnout
2021-04-28 00:00:008-KStáhnout
2021-03-03 00:00:008-KStáhnout
2021-03-02 23:00:008-KStáhnout
2021-02-25 00:00:0010-KStáhnout
2021-02-24 23:00:0010-KStáhnout
2021-02-23 00:00:008-KStáhnout
2021-02-22 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-22 00:00:008-KStáhnout
2020-12-21 23:00:008-KStáhnout
2020-11-10 00:00:008-KStáhnout
2020-11-09 23:00:008-KStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-05 00:00:0010-QStáhnout
2020-11-04 23:00:008-KStáhnout
2020-11-04 23:00:0010-QStáhnout
2020-10-26 00:00:008-KStáhnout
2020-10-25 23:00:008-KStáhnout
2020-08-04 01:00:0010-QStáhnout
2020-08-04 00:00:0010-QStáhnout
2020-07-30 01:00:008-KStáhnout
2020-07-30 00:00:008-KStáhnout
2020-07-28 01:00:008-KStáhnout
2020-07-28 00:00:008-KStáhnout
2020-07-24 01:00:008-KStáhnout
2020-07-24 00:00:008-KStáhnout
2020-07-15 01:00:008-KStáhnout
2020-07-15 00:00:008-KStáhnout
2020-07-07 01:00:008-KStáhnout
2020-07-07 00:00:008-KStáhnout
2020-06-29 01:00:008-KStáhnout
2020-06-29 00:00:008-KStáhnout
2020-05-18 01:00:008-KStáhnout
2020-05-18 00:00:008-KStáhnout
2020-05-04 01:00:0010-QStáhnout
2020-05-04 00:00:0010-QStáhnout
2020-04-28 01:00:008-KStáhnout
2020-04-28 00:00:008-KStáhnout
2020-04-22 01:00:008-KStáhnout
2020-04-22 00:00:008-KStáhnout
2020-03-05 00:00:0010-KStáhnout
2020-03-04 23:00:0010-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-02-05 00:00:008-KStáhnout
2020-02-04 23:00:008-KStáhnout
2020-01-13 00:00:008-KStáhnout
2020-01-12 23:00:008-KStáhnout
2019-12-16 00:00:008-KStáhnout
2019-12-15 23:00:008-KStáhnout
2019-11-14 00:00:008-KStáhnout
2019-11-13 23:00:008-KStáhnout
2019-11-05 00:00:0010-QStáhnout
2019-11-04 23:00:0010-QStáhnout
2019-10-28 00:00:008-KStáhnout
2019-10-27 23:00:008-KStáhnout
2019-08-13 01:00:0010-QStáhnout
2019-08-13 00:00:0010-QStáhnout
2019-08-12 01:00:008-KStáhnout
2019-08-12 00:00:008-KStáhnout
2019-06-04 01:00:008-KStáhnout
2019-06-04 00:00:008-KStáhnout
2019-05-07 01:00:0010-QStáhnout
2019-05-07 00:00:0010-QStáhnout
2019-05-02 01:00:008-KStáhnout
2019-05-02 00:00:008-KStáhnout
2019-03-12 00:00:0010-KStáhnout
2019-03-11 23:00:0010-KStáhnout
2019-03-07 00:00:008-KStáhnout
2019-03-06 23:00:008-KStáhnout
2019-02-01 00:00:008-KStáhnout
2019-01-31 23:00:008-KStáhnout
2019-01-28 00:00:008-KStáhnout
2019-01-27 23:00:008-KStáhnout
2018-11-13 00:00:008-KStáhnout
2018-11-12 23:00:008-KStáhnout
2018-11-06 00:00:0010-QStáhnout
2018-11-05 23:00:0010-QStáhnout
2018-11-01 00:00:008-KStáhnout
2018-10-31 23:00:008-KStáhnout
2018-09-17 01:00:008-KStáhnout
2018-09-17 00:00:008-KStáhnout
2018-09-13 01:00:008-KStáhnout
2018-09-13 00:00:008-KStáhnout
2018-08-06 01:00:008-KStáhnout
2018-08-06 01:00:0010-QStáhnout
2018-08-06 00:00:008-KStáhnout
2018-08-06 00:00:0010-QStáhnout
2018-05-29 01:00:008-KStáhnout
2018-05-29 00:00:008-KStáhnout
preloader